Clinical Trials for Mesothelioma Patients: Vandetanib Contact Information
Read more here to obtain contact information for the facilities participating in the current clinical trial being conducted to study the effects of Vandetanib for patients who have been diagnosed with mesothelioma. Please note: this information is provided by Weitz & Luxenberg for informational purposes only.
Locations:Germany
Heidelberg, Germany
Essen, Germany
Hamburg, Germany
Halle-Dolau, Germany
Switzerland
Zurich, Switzerland
Chur, Switzerland
Contact:
AstraZeneca Switzerland Clinical Study Information
+0041 41 725 76 14
If you or a loved one has been diagnosed with an Asbestos illness like mesothelioma, lung cancer or asbestosis, complete the form on this page to get a FREE and prompt review of your case by a leading Asbestos attorney. Weitz & Luxenberg is a leading mesothelioma law firm with a substantial history of success in asbestos exposure cases.

Patient inclusion criteria for Vandetanib drug study on mesothelioma